As of 4:14pm ET
| +0.97 / +1.32%|
The 20 analysts offering 12-month price forecasts for Gilead Sciences have a median target of 102.50, with a high estimate of 124.00 and a low estimate of 80.00. The median estimate represents a +37.94% increase from the last price of 74.31.
The current consensus among 28 polled investment analysts is to Buy stock in Gilead Sciences. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.